Thrombogenicity test results demonstrated that both the test devices (SSS) and control devices (OM) did not meet the internal specification of non-thrombogenic .
Source facts
Action
The recalling firm issued a notification letter to their sales representatives via email on 3/29/2018 with a response form. For customers who did not return the response form, their will be a subsequent email or fax to their sales rep. The company will continue to follow up via phone and email as needed. The letter identified the affected product, problem and actions to be taken.
Initiated
2018-03-29
Root cause
Use error
Terminated
2020-07-28
Distribution
Worldwide Distribution - US Nationwide and Canada
Recall number
Z-2426-2018
Recall status
Terminated
CDRH record ID
165201
FDA record created
2018-07-12
Recall event number
80324
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.